PharVision Advisers’s TIM SA TIMB Stock Holding History

PharVision Advisers’s Portfolio TIMB Stock Details TIMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,683	Closed	-$208K	–	595
2025 Q4	$208K	Buy	+10,683	New	+$235K	0.11%	526

Other funds holding TIMB

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

PharVision Advisers's TIMB Position: Q1 2026 in Review

PharVision Advisers sold out of TIM SA (TIMB) in Q1 2026, closing a stake of 10,683 shares — an estimated $208K sold.

PharVision Advisers first reported a position in TIMB in Q4 2025 and held it in 1 quarter. The position peaked at $208K in Q4 2025. 164 funds tracked by Wall St. Rank hold TIMB as of Q1 2026.

PharVision Advisers reported no remaining TIM SA position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 10,683 TIM SA shares in Q1 2026, an estimated $208K.
PharVision Advisers first reported a position in TIM SA in Q4 2025 and held it in 1 quarter.
PharVision Advisers's TIM SA position peaked at $208K in Q4 2025.
164 funds tracked by Wall St. Rank held TIM SA as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.